Abstract
Tumor cell plasticity contributes to metastatic competence and is related to tumor heterogeneity, reccurence and treatment failure. Melanomas have high propensity to metastasis and frequently become drug resistant. Although patient survival has significantly increased with the more recent therapeutic modalities, as molecular targeted therapies and immunotherapies, majority patients presen…